Deutsch English Français

Contact

EP2823068

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP2823068

EP2823068 - METHODS AND COMPOSITIONS FOR DETERMINING VIRUS SUSCEPTIBILITY TO NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 16.09.2016 Database last updated on 03.10.2024
Most recent event Tooltip	16.09.2016	Application deemed to be withdrawn	published on 19.10.2016 [2016/42]
Applicant(s)	For all designated states Laboratory Corporation of America Holdings 358 South Main Street Burlington, North Carolina 27215 / US
	[2015/03]
Inventor(s)	01 / HADDAD, Mojgan 80 Muth Drive Orinda California 94523 / US
	02 / PETROPOULOS, Christos John 415 Garcia Avenue Half Moon Bay California 94019 / US
	[2015/03]
Representative(s)	Donald, Jenny Susan Forresters IP LLP Skygarden Erika-Mann-Strasse 11 80636 München / DE
	[N/P]
Former [2015/03]	Donald, Jenny Susan Forresters Skygarden Erika-Mann-Strasse 11 80636 München / DE
Application number, filing date	13755770.8	04.03.2013
	WO2013US28878
Priority number, date	US201261606362P	02.03.2012 Original published format: US 201261606362 P
	[2015/03]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO2013131087
	Date:	06.09.2013
	Language:	EN
	[2013/36]
	Type:	A2 Application without search report
	No.:	EP2823068
	Date:	14.01.2015
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 06.09.2013 takes the place of the publication of the European patent application.
	[2015/03]
Search report(s)	International search report - published on:	US	23.10.2014
	(Supplementary) European search report - dispatched on:	EP	22.09.2015
Classification	IPC:	C12Q1/70	[2015/03]
	CPC:	C12Q1/703 (EP,US); C12Q2600/106 (EP,US); C12Q2600/156 (EP,US)
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2015/03]
Title	German:	VERFAHREN UND ZUSAMMENSETZUNGEN ZUR BESTIMMUNG DER VIRENANFÄLLIGKEIT FÜR NICHTNUCLEOSIDISCHE REVERSE-TRANSKRIPTASE-HEMMER	[2015/03]
	English:	METHODS AND COMPOSITIONS FOR DETERMINING VIRUS SUSCEPTIBILITY TO NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS	[2015/03]
	French:	PROCÉDÉS ET COMPOSITIONS POUR LA DÉTERMINATION DE LA SENSIBILITÉ D'UN VIRUS VIS-À-VIS D'INHIBITEURS DE TRANSCRIPTASE INVERSE NON NUCLÉOSIDES	[2015/03]
Entry into regional phase	01.09.2014	National basic fee paid
	01.09.2014	Search fee paid
	01.09.2014	Designation fee(s) paid
	01.09.2014	Examination fee paid
Examination procedure	01.09.2014	Examination requested [2015/03]
	30.04.2015	Amendment by applicant (claims and/or description)
	20.04.2016	Application deemed to be withdrawn, date of legal effect [2016/42]
	30.05.2016	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time [2016/42]
Fees paid	Renewal fee
	10.03.2015	Renewal fee patent year 03
	10.03.2016	Renewal fee patent year 04
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[XY]WO0222781 (VIROLOGIC INC [US]) [X] 1-15 * abstract * * page 5, line 21 - line 23 * * page 14, line 2 - line 14 * * page 20, line 5 - line 9 * * page 22, line 17 - line 20 * * page 85, line 22 - line 31 * [Y] 3-6,8-13;
		[XY]WO2009061856 (SALK INSTITUITE FOR BIOLOG STU [US], et al) [X] 1-15 * abstract * * page 12, line 9 - line 15 * * page 15, line 9 - line 24 * * page 80, line 29 - page 81, line 3; claims 45-47 * [Y] 3-6,8-13;
		[XY] - TOSSONIAN H K ET AL, "Primary drug resistance in antiretroviral-naive injection drug users", INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, INTERNATIONAL SOCIETY FOR INFECTIOUS DISEASES, HAMILTON, CA, vol. 13, no. 5, doi:10.1016/J.IJID.2008.08.028, ISSN 1201-9712, (20090901), pages 577 - 583, (20090824), XP026502293 [X] 1,2,7,14,15 * abstract * [Y] 3-6,8-13 DOI: http://dx.doi.org/10.1016/j.ijid.2008.08.028
	International search	[X]US2004063191 (HUANG WEI [US], et al);
		[A]US2006094020 (PARKIN NEIL T [US], et al);
		[Y]WO2010130731 (VIRCO BVBA [BE], et al);
		[A] - ESHLEMAN ET AL., "Phenotypic drug resistance patterns in subtype A HIV-1 clones with nonnucleoside reverse transcriptase resistance mutations", AIDS RESEARCH AND HUMAN RETROVIRUSES, (20060301), vol. 22, no. 3, pages 289 - 293, XP055160870 DOI: http://dx.doi.org/10.1089/aid.2006.22.289
		[A] - HINKLEY ET AL., "A systems analysis of mutational effects in HIV-1 protease and reverse transcriptase", NATURE GENETICS, (20110327), vol. 43, no. 5, pages 487 - 490, XP055160872 DOI: http://dx.doi.org/10.1038/ng.795

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p